Matches in Wikidata for { <http://www.wikidata.org/entity/Q82795101> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q82795101 description "artículu científicu espublizáu n'avientu de 2008" @default.
- Q82795101 description "scientific article published on 01 December 2008" @default.
- Q82795101 description "wetenschappelijk artikel" @default.
- Q82795101 description "наукова стаття, опублікована в грудні 2008" @default.
- Q82795101 name "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 name "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 type Item @default.
- Q82795101 label "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 label "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 prefLabel "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 prefLabel "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 P1433 Q82795101-E1194282-9FA8-4586-A503-3DF3E4BB29C5 @default.
- Q82795101 P1476 Q82795101-8B699F0B-47B5-476D-9E35-6F067C1CC1DF @default.
- Q82795101 P2093 Q82795101-2693CD9D-2B70-4772-8E6B-3AF1F76D8D13 @default.
- Q82795101 P2093 Q82795101-2D25AFFC-33C8-4379-8FA0-A76F35DBA164 @default.
- Q82795101 P2093 Q82795101-73F0E4DF-927C-48C5-BED1-8A53C0FB3D58 @default.
- Q82795101 P2093 Q82795101-B4B0C882-1B06-42A0-A1BB-779960B65C7F @default.
- Q82795101 P304 Q82795101-1CDCF73D-CACC-478A-A830-D9D32930F113 @default.
- Q82795101 P31 Q82795101-518F4EB2-E1CD-4C88-941A-0910B8AA3B63 @default.
- Q82795101 P356 Q82795101-2C76CB56-4942-45DF-BE89-F064D5D18AE0 @default.
- Q82795101 P433 Q82795101-5CD87AA5-D078-4EB7-BAEF-1371CF85E023 @default.
- Q82795101 P478 Q82795101-E2519A1A-CA3B-4504-BCA4-5EDDD3284863 @default.
- Q82795101 P50 Q82795101-C0AF9292-0E2D-4369-910C-9E743CE300DF @default.
- Q82795101 P50 Q82795101-DB3C7C68-BA09-4490-8E57-7E71F0153EEF @default.
- Q82795101 P50 Q82795101-EBC396EE-D96F-4247-B1B7-054CC3FB37E1 @default.
- Q82795101 P577 Q82795101-F652AF1D-4463-4D14-B9DD-738C40A76ACF @default.
- Q82795101 P698 Q82795101-5A6F8665-E064-4452-AEB5-60F72D424E18 @default.
- Q82795101 P921 Q82795101-002A770D-1245-4443-91D2-99DAC19BAFB4 @default.
- Q82795101 P921 Q82795101-39E1DD38-931B-422F-885A-64AD457469AF @default.
- Q82795101 P921 Q82795101-9E060206-6B10-482A-9C39-31866AAF5FB8 @default.
- Q82795101 P356 000178810 @default.
- Q82795101 P698 19047813 @default.
- Q82795101 P1433 Q2016300 @default.
- Q82795101 P1476 "Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile" @default.
- Q82795101 P2093 "Carlo Buzio" @default.
- Q82795101 P2093 "Domenico Potenzoni" @default.
- Q82795101 P2093 "Rodolfo Passalacqua" @default.
- Q82795101 P2093 "Umberto Maggiore" @default.
- Q82795101 P304 "69-76" @default.
- Q82795101 P31 Q13442814 @default.
- Q82795101 P356 "10.1159/000178810" @default.
- Q82795101 P433 "1" @default.
- Q82795101 P478 "76" @default.
- Q82795101 P50 Q37835022 @default.
- Q82795101 P50 Q46052524 @default.
- Q82795101 P50 Q80546437 @default.
- Q82795101 P577 "2008-12-01T00:00:00Z" @default.
- Q82795101 P698 "19047813" @default.
- Q82795101 P921 Q1164529 @default.
- Q82795101 P921 Q1427096 @default.
- Q82795101 P921 Q19000948 @default.